Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 57664-951

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate (NDC 57664-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Mixedamphetamine 01)

A pharmacokinetic graph showing mean concentrations (ng/mL) of d-amphetamine and l-amphetamine over time (hours) from 0 to 60 hours. The chart compares extended-release capsules containing Dextroamphetamine saccharate, Amphetamine aspartate monohydrate, Dextroamphetamine sulfate, and Amphetamine sulfate (37.5 mg) with a combination of MAS-ER 25 mg and MAS-IR 12.5 mg dosages. Concentration curves for both d- and l-amphetamine are plotted with distinct markers and dashed lines.*

FDA Label Image

Figure 2 (Mixedamphetamine 02)

A line graph depicting least-squares mean (LS Mean) PERMP total scores over time post-dose (in hours) comparing placebo and Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release capsules. The graph shows score trends with error bars indicating standard error across time points from approximately -0.5 to 16 hours post-dose.*

FDA Label Image

12.5 mg (Mixed Amphetamines 12 5mg)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules 12.5 mg. The label shows the drug name with dosage strength prominently, instructions for pharmacists, capsule count of 100, and manufacturer Sun Pharmaceutical Industries. It includes dosage component details, usage notes, barcodes, and storage instructions.*

FDA Label Image

25 mg (Mixed Amphetamines 25mg)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate extended-release capsules, 25 mg strength. The label shows the product name, dosage form as extended-release capsules, manufacturer Sun Pharmaceutical Industries, Inc., NDC 57664-951-88, quantity of 100 capsules, and usage instructions indicating once-daily administration with a warning not to substitute for Adderall XR.*

FDA Label Image

37.5 mg (Mixed Amphetamines 37 5mg)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules, 37.5 mg. The label includes dosage strength, dosing instructions to take once daily, pharmacist dispensing note, and packaging size of 100 capsules. Manufactured by Sun Pharmaceutical Industries, Inc., with storage instructions and NDC number 57664-952-88 visible.*

FDA Label Image

50 mg (Mixed Amphetamines 50mg)

Label for Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules, 50 mg strength. The label indicates a quantity of 100 capsules, for once-daily use, and notes it is not a substitute for Adderall XR. Manufactured by Sun Pharmaceutical Industries, Inc., with storage instructions and a barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.